Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction
Abstract
To examine the fibrinolytic capacity in patients with acute myocardial infarction (AMI), baseline levels of plasma plasminogen activator inhibitor (PAI) activity and tissue-type plasminogen activator (t-PA) antigen were measured in 47 patients with Q-wave AMI who underwent emergent coronary angiography 3.0 +/- 0.2 hours after the symptom onset. They received intracoronary injection of urokinase if their infarct-related arteries were occluded. They were classified into 3 groups according to the patency of the infarct-related artery before and after thrombolytic therapy: the patent group (13 patients), the recanalized group (23 patients) and the occluded group (11 patients). The mean level of plasma PAI activity (IU/ml) was higher in patients with AMI as a whole than in the control group (12.8 +/- 1.6 vs 5.4 +/- 0.5, p less than 0.01). The level was lower in the patent group (3.0 +/- 1.1) and higher in the recanalized (18.6 +/- 2.2) and occluded (10.8 +/- 2.5) groups than in the control group (each p less than 0.01). The level was lower in the occluded than in the recanalized group (p less than 0.01) and 62% of the patients in the occluded group had levels within range of the control group. The mean level of plasma t-PA antigen (ng/ml) was higher in patients with AMI as a whole than in the control group (10.3 +/- 0.8 vs 5.8 +/- 0.3, p less than 0.01). There was no difference in the level among the 3 groups with AMI.(ABSTRACT TRUNCATED AT 250 WORDS)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In recent reports on the association of CRP and fibrinogen with mean IMT and coronary artery calcium score in Japanese, Japanese-American, and Caucasian populations, a significant association was not seen in any of the races after adjustment for multiple variables or for age and BMI.
“By contrast, some recent reports on the association of CRP and fibrinogen with mean IMT and coronary artery calcium score in the Japanese, Japanese–American, and Caucasian populations have stated that a significant association was not seen in any of the races after adjustment for multiple variables (age, SBP, LDL-C, HDL-C, fasting glucose level, smoking, and alcohol consumption) or for age and BMI”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [301]
Cites
The Thrombolysis in Myocardial Infarction (TIMI) Trial
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,192 · see citing works
Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
DeWood, M. A., Spores, J., Notske, R. N., Mouser, L. T., Burroughs, R., Golden, M. S., & Lang, H. T. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010163031601 · Cited by 2,729 · see citing works
Plasminogen activator inhibitors
Sprengers, E. D., & Kluft, C. (1987) · Blood · doi:10.1182/blood.v69.2.381.bloodjournal692381 · Cited by 936 · see citing works
Coronary Vasospasm as a Possible Cause of Myocardial Infarction
Maseri, A., L’Abbate, A., Baroldi, G., Chierchia, S. L., Marzilli, M., Ballestra, A. M., Severi, S., Parodi, O., Biagini, A., Distante, A., et al. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812072992303 · Cited by 841 · see citing works
Plasminogen activator inhibitors
Sprengers, E. D., & Kluft, C. (1987) · Blood · doi:10.1182/blood.v69.2.381.381 · Cited by 780 · see citing works
C-REACTIVE PROTEIN FIFTY YEARS ON
Pepys, M. B. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91565-8 · Cited by 686 · see citing works
Gunnar, R. M., Bourdillon, P. D. V., Dixon, D. W., Fuster, V., Karp, R. B., Kennedy, J. W., Klocke, F. J., Passamani, E. R., Pitt, B., & Rapaport, E. (1990) · Circulation · doi:10.1161/01.cir.82.2.664 · Cited by 486 · see citing works
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
Chmielewska, J., Rånby, M., & Wiman, B. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90407-3 · Cited by 471 · see citing works
Creatine kinase in serum: 1. Determination of optimum reaction conditions.
Szász, G., Gruber, W., & Bernt, E. (1976) · Clinical Chemistry · doi:10.1093/clinchem/22.5.650 · Cited by 447 · see citing works
Colucci, M., Páramo, J. A., & Collen, D. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111777 · Cited by 399 · see citing works
The second biological revolution.
Huxley, J. S. (1946) · PubMed · Cited by 389 · see citing works
Intracoronary Fibrinolytic Therapy in Acute Myocardial Infarction
Khaja, F., Walton, J. A., Brymer, J. F., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306023082201 · Cited by 379 · see citing works
Collen, D., Topol, E. J., Tiefenbrunn, A. J., Gold, H. K., Weisfeldt, M. L., Sobel, B. E., Leinbach, R. C., Brinker, J. A., Ludbrook, P. A., & Yasuda, I. (1984) · Circulation · doi:10.1161/01.cir.70.6.1012 · Cited by 376 · see citing works
Gold, H. K., Leinbach, R. C., Garabedian, H., et al. (1986) · Circulation · doi:10.1161/01.cir.73.2.347 · Cited by 293 · see citing works
Williams, D. O., BORER, J. S., D, E. B. M., et al. (1986) · Circulation · doi:10.1161/01.cir.73.2.338 · Cited by 291 · see citing works
Rentrop, K. P., Feit, F., Blanke, H., Stecy, P. J., Schneider, R., Rey, M. J., Horowitz, S. M., Goldman, M., Karsch, K. R., Meilman, H., et al. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412063112301 · Cited by 284 · see citing works
Zamarron, C., LIJNEN, H. R., & Collen, D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43319-9 · Cited by 157 · see citing works
Lucore, C. L., & Sobel, B. E. (1988) · Circulation · doi:10.1161/01.cir.77.3.660 · Cited by 138 · see citing works
Eriksson, E., Rånby, M., Gyzander, E., et al. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90177-6 · Cited by 123 · see citing works
Almér, L., & Öhlin, H. (1987) · Thrombosis Research · doi:10.1016/0049-3848(87)90147-2 · Cited by 111 · see citing works
Barbash, G. I., Hod, H., Roth, A., et al. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90559-6 · Cited by 74 · see citing works
Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level
Wun, T., & Capuano, A. (1987) · Blood · doi:10.1182/blood.v69.5.1354.1354 · Cited by 63 · see citing works
Andreotti, F., Roncaglioni, M. C., Hackett, D. R., et al. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90300-e · Cited by 58 · see citing works
Gram, J., Kluft, C., & Jespersen, J. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1645996 · Cited by 51 · see citing works
Amiral, J., Plassart, V., Grosley, M., et al. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90159-4 · Cited by 34 · see citing works
Tuengler, P., Metzmann, E., He, P., & Becker, W. (1988) · PubMed · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works
- Authors
- Sakamoto, T., Yasue, H., Ogawa, H., Misumi, I., & Masuda, T.
- Affiliations
- Kumamoto University (JP)
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1992-08
- Volume
- 70
- Issue
- 3
- Pages
- 271-276
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2051364696
- Cited by
- 49
- References
- 26
- Citations by year
- 2023: 1 · 2021: 1 · 2018: 1 · 2014: 2 · 2012: 1
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education
- Smoking Research Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Keywords
- acute myocardial infarction, plasminogen activator inhibitor, tissue plasminogen activator, fibrinolysis, coronary recanalization, coronary artery occlusion, urokinase thrombolysis, Q-wave myocardial infarction
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antigens, Arteries, Coronary Vessels, Female, Humans, Male, Middle Aged, Myocardial Infarction, Tissue Plasminogen Activator, Urokinase-Type Plasminogen Activator, Vascular Patency, Plasminogen Inactivators, Thrombolytic Therapy, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review